These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 9368838

  • 1. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI.
    J Comp Neurol; 1997 Nov 17; 388(2):211-27. PubMed ID: 9368838
    [Abstract] [Full Text] [Related]

  • 2. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M, Desmond TJ, Albin RL, Frey KA.
    Synapse; 2001 Sep 15; 41(4):329-36. PubMed ID: 11494403
    [Abstract] [Full Text] [Related]

  • 3. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization.
    Svingos AL, Clarke CL, Pickel VM.
    Synapse; 1999 Oct 15; 34(1):1-10. PubMed ID: 10459166
    [Abstract] [Full Text] [Related]

  • 4. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
    Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM.
    J Neurosci; 1996 Jan 15; 16(2):436-47. PubMed ID: 8551328
    [Abstract] [Full Text] [Related]

  • 5. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG, Dziewczapolski G, Menalled LB, García MC, Agid Y, Gershanik O, Raisman-Vozari R.
    Ann Neurol; 1998 May 15; 43(5):561-75. PubMed ID: 9585350
    [Abstract] [Full Text] [Related]

  • 6. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN, Ryoo H, Cox C, Lu W.
    J Comp Neurol; 1995 Nov 20; 362(3):400-10. PubMed ID: 8576447
    [Abstract] [Full Text] [Related]

  • 7. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
    Pickel VM, Chan J, Nirenberg MJ.
    Synapse; 2002 Aug 20; 45(2):113-24. PubMed ID: 12112404
    [Abstract] [Full Text] [Related]

  • 8. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.
    Sesack SR, Aoki C, Pickel VM.
    J Neurosci; 1994 Jan 20; 14(1):88-106. PubMed ID: 7904306
    [Abstract] [Full Text] [Related]

  • 9. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine.
    Han S, Rowell PP, Carr LA.
    Res Commun Mol Pathol Pharmacol; 1999 Jan 20; 104(3):331-8. PubMed ID: 10741383
    [Abstract] [Full Text] [Related]

  • 10. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
    Deng YP, Lei WL, Reiner A.
    J Chem Neuroanat; 2006 Dec 20; 32(2-4):101-16. PubMed ID: 16914290
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ.
    J Pharmacol Exp Ther; 2001 Jul 20; 298(1):129-40. PubMed ID: 11408534
    [Abstract] [Full Text] [Related]

  • 12. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron.
    Pickel VM, Garzón M, Mengual E.
    Prog Brain Res; 2002 Jul 20; 136():145-55. PubMed ID: 12143378
    [Abstract] [Full Text] [Related]

  • 13. Regional and subcellular compartmentation of the dopamine transporter and tyrosine hydroxylase in the rat ventral pallidum.
    Mengual E, Pickel VM.
    J Comp Neurol; 2004 Jan 12; 468(3):395-409. PubMed ID: 14681933
    [Abstract] [Full Text] [Related]

  • 14. Dopamine innervation of the monkey mediodorsal thalamus: Location of projection neurons and ultrastructural characteristics of axon terminals.
    Melchitzky DS, Erickson SL, Lewis DA.
    Neuroscience; 2006 Dec 28; 143(4):1021-30. PubMed ID: 17029800
    [Abstract] [Full Text] [Related]

  • 15. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
    Lessard A, Grady EF, Bunnett NW, Pickel VM.
    Neuroscience; 2007 Feb 23; 144(4):1393-408. PubMed ID: 17197098
    [Abstract] [Full Text] [Related]

  • 16. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M.
    J Comp Neurol; 2004 Nov 08; 479(2):198-215. PubMed ID: 15452855
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 18. Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
    Hattori T, Takada M, Moriizumi T, Van der Kooy D.
    J Comp Neurol; 1991 Jul 15; 309(3):391-401. PubMed ID: 1717519
    [Abstract] [Full Text] [Related]

  • 19. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 20. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.
    Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ.
    Ann Neurol; 1996 Sep 15; 40(3):428-39. PubMed ID: 8797532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.